Clinical Trial Update: Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD [NA]

View source ↗

Summary

A clinical trial comparing genotype-guided selection of oral P2Y12 inhibitors versus conventional clopidogrel therapy in symptomatic intracranial atheroscleroti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerotic Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Intracranial Atherosclerosis | NA | Status: RECRUITING